The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used psychopharmaceutical treatment for major depressive disorder (MDD), but individual responses to SSRIs vary greatly. CYP2C19 is a key enzyme involved in the metabolism of several drugs, including SSRIs. Variations in the CYP2C...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Win Lee Edwin, Fabbri, Chiara, Laplace, Benjamin, Li, Danyang, van Westrhenen, Roos, Lewis, Cathryn M., Dawe, Gavin Stewart, Young, Allan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535191/
https://www.ncbi.nlm.nih.gov/pubmed/37765085
http://dx.doi.org/10.3390/ph16091277

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535191/
https://www.ncbi.nlm.nih.gov/pubmed/37765085
http://dx.doi.org/10.3390/ph16091277

Ejemplares similares